| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1002063225 |
| P356 | DOI | 10.1007/S00436-014-3969-7 |
| P698 | PubMed publication ID | 24894082 |
| P50 | author | Amira Taman | Q61142420 |
| P2093 | author name string | Manar Azab | |
| P2860 | cites work | The global programme to eliminate lymphatic filariasis: health impact after 8 years | Q21092299 |
| Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis | Q21198915 | ||
| Artemisinins and synthetic trioxolanes in the treatment of helminth infections | Q22061831 | ||
| Current perspectives on the mechanism of action of artemisinins | Q22061943 | ||
| Interventions for treating scabies | Q24244137 | ||
| Diethylcarbamazine activity against Brugia malayi microfilariae is dependent on inducible nitric-oxide synthase and the cyclooxygenase pathway | Q24815903 | ||
| Serotonin signaling in Schistosoma mansoni: a serotonin-activated G protein-coupled receptor controls parasite movement | Q27331388 | ||
| Artemisinins: their growing importance in medicine | Q27489880 | ||
| Elimination of human onchocerciasis: History of progress and current feasibility using ivermectin (Mectizan®) monotherapy | Q27692519 | ||
| Mechanism of action of reagents that uncouple oxidative phosphorylation | Q28237551 | ||
| Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis | Q28277486 | ||
| The nicotinic acetylcholine receptors of the parasitic nematode Ascaris suum: formation of two distinct drug targets by varying the relative expression levels of two subunits | Q28475744 | ||
| A novel G protein-coupled receptor of Schistosoma mansoni (SmGPR-3) is activated by dopamine and is widely expressed in the nervous system | Q28481302 | ||
| Characterization of a truncated metabotropic glutamate receptor in a primitive metazoan, the parasitic flatworm Schistosoma mansoni | Q34070596 | ||
| Initial observation on albendazole in combination with cimetidine for the treatment of human cystic echinococcosis | Q34341798 | ||
| Identification of a Drosophila melanogaster glutamate-gated chloride channel sensitive to the antiparasitic agent avermectin | Q34388555 | ||
| Glutamate-gated chloride channels and the mode of action of the avermectin/milbemycin anthelmintics | Q34506345 | ||
| Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials | Q34939414 | ||
| New policies for using anthelmintics in high risk groups | Q34959693 | ||
| Use of benzimidazoles in children younger than 24 months for the treatment of soil-transmitted helminthiasis | Q35126821 | ||
| Are Ca2+ channels targets of praziquantel action? | Q35993816 | ||
| Treatment strategies underpinning the global programme to eliminate lymphatic filariasis | Q36066068 | ||
| Loa loa encephalopathy temporally related to ivermectin administration reported from onchocerciasis mass treatment programs from 1989 to 2001: implications for the future | Q36287263 | ||
| Classical transmitters and their receptors in flatworms | Q36434064 | ||
| Intestinal cestodes | Q36925515 | ||
| Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar | Q36947786 | ||
| Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle | Q37090661 | ||
| Praziquantel treatment in trematode and cestode infections: an update | Q37192109 | ||
| Developmental expression analysis and immunolocalization of a biogenic amine receptor in Schistosoma mansoni | Q37293961 | ||
| Artemisinin-naphthoquine combination (ARCO) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: a preliminary report on safety and efficacy | Q37325659 | ||
| Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges | Q37405246 | ||
| Unresolved issues in anthelmintic pharmacology for helminthiases of humans | Q37636980 | ||
| Control of nematode parasites with agents acting on neuro-musculature systems: lessons for neuropeptide ligand discovery. | Q37824390 | ||
| Progress and challenges in the discovery of macrofilaricidal drugs | Q37912232 | ||
| Advances in the discovery and development of trematocidal drugs | Q38089167 | ||
| Artemether shows promising female schistosomicidal and ovicidal effects on the Egyptian strain of Schistosoma mansoni after maturity of infection. | Q38856397 | ||
| Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children | Q38860009 | ||
| Severe reactions to filarial chemotherapy and release of Wolbachia endosymbionts into blood. | Q38956749 | ||
| Triclabendazole in the treatment of human fascioliasis: a community-based study | Q38988844 | ||
| Triclabendazole and its two main metabolites lack activity against Schistosoma mansoni in the mouse model. | Q39126736 | ||
| Schistosome calcium channel beta subunits. Unusual modulatory effects and potential role in the action of the antischistosomal drug praziquantel | Q39143568 | ||
| Effect of a novel benzimidazole derivative in experimental Schistosoma mansoni infection. | Q39338872 | ||
| Efficacy of ivermectin in the treatment of strongyloidiasis complicating AIDS. | Q39530129 | ||
| Comparative study of the effects of artemether and artesunate on juvenile and adult Schistosoma mansoni in experimentally infected mice | Q39544928 | ||
| Investigation of a dopamine receptor in Schistosoma mansoni: functional studies and immunolocalization | Q39834861 | ||
| The general immunopharmacology of levamisole | Q40287927 | ||
| Bacterial endosymbionts of Onchocerca volvulus in the pathogenesis of posttreatment reactions | Q40585819 | ||
| Target sites of anthelmintics. | Q40911396 | ||
| Neuromuscular physiology and pharmacology of parasitic flatworms | Q41365099 | ||
| Inhibition of heme aggregation by chloroquine reduces Schistosoma mansoni infection | Q41913699 | ||
| A novel Schistosoma mansoni G protein-coupled receptor is responsive to histamine | Q42665977 | ||
| Treatment of human pulmonary paragonimiasis with triclabendazole: clinical tolerance and drug efficacy | Q42688544 | ||
| Artemisinins inhibit Trypanosoma cruzi and Trypanosoma brucei rhodesiense in vitro growth | Q42845988 | ||
| Histamine signalling in Schistosoma mansoni: immunolocalisation and characterisation of a new histamine-responsive receptor (SmGPR-2). | Q43080018 | ||
| Fasciola gigantica: Parasitological and scanning electron microscopy study of the in vitro effects of ivermectin and/or artemether | Q43253916 | ||
| Volatile components of four Ethiopian Artemisia species extracts and their in vitro antitrypanosomal and cytotoxic activities | Q43291240 | ||
| Artemether administered together with haemin damages schistosomes in vitro | Q43560771 | ||
| Assessing the risk of benzimidazole therapy during pregnancy | Q43560773 | ||
| Tegumental changes in 21-day-old Schistosoma mansoni harboured in mice treated with artemether | Q43649169 | ||
| Evidence for the presence of glutamatergic receptors in adult Schistosoma mansoni | Q44188958 | ||
| Pregnancy outcome after inadvertent ivermectin treatment during community-based distribution | Q44310207 | ||
| The effects of diethylcarbamazine on the ultrastructure of microfilariae of Wuchereria bancrofti in vivo and in vitro | Q44791062 | ||
| Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment | Q44795124 | ||
| First insight into the effect of single oral dose therapy with artemisinin-naphthoquine phosphate combination in a mouse model of Schistosoma mansoni infection | Q44917077 | ||
| Triggering of high-level resistance against Schistosoma mansoni reinfection by artemether in the mouse model. | Q45219025 | ||
| Antiparasitic drugs in neurocysticercosis: albendazole or praziquantel? | Q46512180 | ||
| Experimental trials of an artemisinin derivative in treatment of Schistosoma mansoni infected mice. | Q46744090 | ||
| Effect of mebendazole therapy during pregnancy on birth outcome | Q47631263 | ||
| Effect of artemether on glucose uptake and glycogen content in Schistosoma japonicum. | Q47844348 | ||
| Mode of action of benzimidazoles | Q47969579 | ||
| Glutamate-mediated signaling in Schistosoma mansoni: a novel glutamate receptor is expressed in neurons and the female reproductive tract | Q48061086 | ||
| In vivo effect of single oral dose of artemether against early juvenile stages of Schistosoma mansoni Egyptian strain. | Q51222274 | ||
| Effect of the in vivo activity of dihydroartemisinin against Schistosoma mansoni infection in mice. | Q51400781 | ||
| Effects of artemether, artesunate and dihydroartemisinin administered orally at multiple doses or combination in treatment of mice infected with Schistosoma japonicum. | Q51456665 | ||
| Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs. | Q52721186 | ||
| Uncoupling of rat liver mitochondrial oxidative phosphorylation by the fasciolicide triclabendazole and its sulfoxide and sulfone metabolites. | Q54243782 | ||
| The anti-schistosomal drug praziquantel is an adenosine antagonist | Q58070149 | ||
| In vivo and in vitro experiments on the effects of praziquantel on Schistosoma mansoni. A light and electron microscopic study | Q70663091 | ||
| Treatment of Paragonimus Westermani Infections with Bithionol | Q71624666 | ||
| Pharmacotherapy of helminth infection | Q83292712 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2425-2433 | |
| P577 | publication date | 2014-06-04 | |
| P1433 | published in | Parasitology Research | Q15755242 |
| P1476 | title | Present-day anthelmintics and perspectives on future new targets | |
| P478 | volume | 113 |
| Q61811472 | Menthol acts as a positive allosteric modulator on nematode levamisole sensitive nicotinic acetylcholine receptors |
| Q50055971 | Metabolism of albendazole, ricobendazole and flubendazole in Haemonchus contortus adults: Sex differences, resistance-related differences and the identification of new metabolites. |
| Q39039243 | MicroRNA-mediated regulation of immune responses to intestinal helminth infections. |
| Q37541737 | Microfluidic platform for electrophysiological recordings from host-stage hookworm and Ascaris suum larvae: A new tool for anthelmintic research |
| Q37123991 | Pharmacological profile of Ascaris suum ACR-16, a new homomeric nicotinic acetylcholine receptor widely distributed in Ascaris tissues |
| Q60921263 | Probiotics and yogurt modulate oxidative stress and fibrosis in livers of Schistosoma mansoni-infected mice |
| Q39003333 | Target-based molecular modeling strategies for schistosomiasis drug discovery. |
Search more.